ONCOLOGIE THORACIQUE : Revue Annuelle

Alexandra F. Leary, David Gonzalez de Castro, Andrew G. Nicholson, Sue Ashley, Andrew Wotherspoon, Mary E.R. O’Brien, Sanjay Popat, Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors. European Journal of Cancer. ,vol. 48, pp. 61- 67 ,(2012) , 10.1016/J.EJCA.2011.09.022

Massimo Di Maio, Simona Signoriello, Alessandro Morabito, Antonio Rossi, Paolo Maione, FrancoVito Piantedosi, Domenico Bilancia, Silvio Cigolari, Santi Barbera, Vittorio Gebbia, Bruno Daniele, Sergio Federico Robbiati, Alfonso Illiano, Anna Ceribelli, Francesco Carrozza, Adolfo Favaretto, Elena Piazza, Maria Carmela Piccirillo, Gennaro Daniele, Pasqualina Giordano, Raffaele Costanzo, Claudia Sandomenico, Gaetano Rocco, Ciro Gallo, Francesco Perrone, Cesare Gridelli, Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials Lung Cancer. ,vol. 76, pp. 457- 464 ,(2012) , 10.1016/J.LUNGCAN.2012.01.002

Miep A. van der Drift, Henrike E. Karim-Kos, Sabine Siesling, Harry J.M. Groen, Michel W.J.M. Wouters, Jan-Willem Coebergh, Esther de Vries, Maryska L.G. Janssen-Heijnen, Progress in Standard of Care Therapy and Modest Survival Benefits in the Treatment of Non-small Cell Lung Cancer Patients in the Netherlands in the Last 20 Years Journal of Thoracic Oncology. ,vol. 7, pp. 291- 298 ,(2012) , 10.1097/JTO.0B013E31823A01FB

Taofeek K. Owonikoko, Madhusmita Behera, Zhengjia Chen, Chandar Bhimani, Walter J. Curran, Fadlo R. Khuri, Suresh S. Ramalingam, A systematic analysis of efficacy of second line chemotherapy in sensitive and refractory small cell lung cancer Journal of Thoracic Oncology. ,vol. 7, pp. 866- 872 ,(2012) , 10.1097/JTO.0B013E31824C7F4B

Marie Brevet, Melissa L. Johnson, Christopher G. Azzoli, Marc Ladanyi, Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors Lung Cancer. ,vol. 73, pp. 96- 102 ,(2011) , 10.1016/J.LUNGCAN.2010.10.014

C. Jungels, T. Berghmans, A.-P. Meert, J.-J. Lafitte, A. Scherpereel, J.-P. Sculier, Traitement de rattrapage par pémétrexed pour les CBNPC : étude rétrospective d’implémentation Revue des Maladies Respiratoires. ,vol. 29, pp. 21- 27 ,(2012) , 10.1016/J.RMR.2011.11.003

Martin J. Edelman, Lydia Hodgson, Paula Y. Rosenblatt, Robert H. Christenson, Everett E. Vokes, Xiaofei Wang, Robert Kratzke, CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304. Journal of Thoracic Oncology. ,vol. 7, pp. 649- 654 ,(2012) , 10.1097/JTO.0B013E31824A8DB0

Rinus Wanders, Jessie Steevens, Anita Botterweck, Anne-Marie C. Dingemans, Bart Reymen, Angela van Baardwijk, Jacques Borger, Gerben Bootsma, Cordula Pitz, Ragnar Lunde, Wiel Geraedts, Philippe Lambin, Dirk De Ruysscher, Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study. European Journal of Cancer. ,vol. 47, pp. 2691- 2697 ,(2011) , 10.1016/J.EJCA.2011.06.023

Jeong-Ok Lee, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Soyeon Kim, Yoon-Kyung Jeon, Doo Hyun Chung, Woo-Ho Kim, Young Tae Kim, Seok-Chul Yang, Young Whan Kim, Dae Seog Heo, Yung-Jue Bang, None, Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer. Journal of Thoracic Oncology. ,vol. 6, pp. 1474- 1480 ,(2011) , 10.1097/JTO.0B013E3182208FC2

Renda Soylemez Wiener, Lisa M. Schwartz, Steven Woloshin, H. Gilbert Welch, Population-Based Risk for Complications After Transthoracic Needle Lung Biopsy of a Pulmonary Nodule: An Analysis of Discharge Records Annals of Internal Medicine. ,vol. 155, pp. 137- 144 ,(2011) , 10.7326/0003-4819-155-3-201108020-00003